Express Pharma
Home  »  Latest Updates  »  Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment

Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment

Regeneron in February announced a partnership with the US Department of Health and Human Services to develop a coronavirus treatment, and had said it would focus on monoclonal antibodies

0 67
Read Article

Sanofi SA and partner Regeneron Pharmaceuticals have started a clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus, the companies reported.

Enrolments for the mid-to-late stage trial will begin immediately, and the companies anticipate the trial will test up to 400 patients.

Kevzara is an infection-fighting protein known as monoclonal antibody.

Regeneron in February announced a partnership with the US Department of Health and Human Services to develop a coronavirus treatment, and had said it would focus on monoclonal antibodies.

Leave A Reply

Your email address will not be published.